Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Timing bond vs index fund choices in retirement affects risk and growth. Learn when to shift allocations for income.
25,546 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Microsoft stock has slipped in 2026, but a strong earnings report could ignite a rebound. This guide breaks down what...
Netflix just changed how it reports engagement, and the move could ripple through NFLX stock moves. This guide breaks...
A bold forecast from Nvidia's founder centers on an AI spending boom. This article breaks down the rationale, the mat...
Redwire stock popped tuesday as the company announced ambitious factory expansions and a second facility for space pa...
Senate Democrats allege the White House granted tariff exemptions to firms tied to donors, sparking a bipartisan push...
Investors are watching Nextdoor's 2025 earnings closely as the Q4 results shed light on monetization of local communi...
Hims & Hers Health announces a major acquisition of Australian digital health firm Eucalyptus, valued at up to $1.15 ...
Berkshire Hathaway cut a large portion of its Amazon position and deployed capital into The New York Times, a calcula...
Investors keep asking: is plug power stock: dead, or does the hydrogen quest still offer a path to strong gains? This...
Keurig Dr Pepper reported stronger-than-expected Q4 results and unveiled an $18 billion deal to acquire JDE Peet's, p...
NVIDIA is expected to report a $65.7 billion Q4 revenue figure as investors weigh margin recovery against AI-driven d...